Thomas Trimarchi - 16 Feb 2025 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
President and COO
Signature
/s/ Thomas Trimarchi
Issuer symbol
BBIO
Transactions as of
16 Feb 2025
Transactions value $
-$480,992
Form type
4
Filing time
19 Feb 2025, 20:51:51 UTC
Previous filing
12 Dec 2024
Next filing
21 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Tax liability -$481K -13.8K -3.22% $34.90 414K 16 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax obligation in connection with the vesting of 32,431 shares of Common Stock underlying the Reporting Person's Restricted Stock Units.